Edmond de Rothschild (Europe)’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Edmond de Rothschild (Europe)’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$5K	Buy	+130	New	+$1.45K	﹤0.01%	229

Other funds holding TBRA

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $214M AUM 88.6% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Edmond de Rothschild (Europe)'s TBRA Position: Q3 2016 in Review

Edmond de Rothschild (Europe) opened a new position in Tobira Therapeutics, Inc. Common Stock (TBRA) in Q3 2016: 130 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #229 among its holdings.

68 funds tracked by Wall St. Rank hold TBRA as of Q3 2016.

Edmond de Rothschild (Europe) held 130 shares of Tobira Therapeutics, Inc. Common Stock worth $5K as of Q3 2016.
Tobira Therapeutics, Inc. Common Stock was a new Edmond de Rothschild (Europe) position in Q3 2016.
Tobira Therapeutics, Inc. Common Stock made up ﹤0.01% of Edmond de Rothschild (Europe)'s portfolio in Q3 2016, its #229 holding.
68 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q3 2016.

Based on Edmond de Rothschild (Europe)'s 13F filing for Q3 2016, filed 14 Nov 2016.